1. Home
  2. NTIC vs ADAP Comparison

NTIC vs ADAP Comparison

Compare NTIC & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTIC
  • ADAP
  • Stock Information
  • Founded
  • NTIC 1970
  • ADAP 2008
  • Country
  • NTIC United States
  • ADAP United Kingdom
  • Employees
  • NTIC N/A
  • ADAP N/A
  • Industry
  • NTIC Industrial Specialties
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTIC Industrials
  • ADAP Health Care
  • Exchange
  • NTIC Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • NTIC 71.5M
  • ADAP 75.5M
  • IPO Year
  • NTIC N/A
  • ADAP 2015
  • Fundamental
  • Price
  • NTIC $8.21
  • ADAP $0.25
  • Analyst Decision
  • NTIC Buy
  • ADAP Buy
  • Analyst Count
  • NTIC 1
  • ADAP 6
  • Target Price
  • NTIC $20.00
  • ADAP $1.35
  • AVG Volume (30 Days)
  • NTIC 84.2K
  • ADAP 660.3K
  • Earning Date
  • NTIC 07-10-2025
  • ADAP 08-11-2025
  • Dividend Yield
  • NTIC 3.44%
  • ADAP N/A
  • EPS Growth
  • NTIC N/A
  • ADAP N/A
  • EPS
  • NTIC 0.38
  • ADAP N/A
  • Revenue
  • NTIC $84,445,763.00
  • ADAP $179,639,000.00
  • Revenue This Year
  • NTIC $2.05
  • ADAP N/A
  • Revenue Next Year
  • NTIC $4.70
  • ADAP $35.48
  • P/E Ratio
  • NTIC $21.30
  • ADAP N/A
  • Revenue Growth
  • NTIC 2.11
  • ADAP 878.53
  • 52 Week Low
  • NTIC $6.75
  • ADAP $0.20
  • 52 Week High
  • NTIC $16.75
  • ADAP $1.48
  • Technical
  • Relative Strength Index (RSI)
  • NTIC 61.95
  • ADAP 44.34
  • Support Level
  • NTIC $7.37
  • ADAP $0.23
  • Resistance Level
  • NTIC $8.43
  • ADAP $0.25
  • Average True Range (ATR)
  • NTIC 0.34
  • ADAP 0.02
  • MACD
  • NTIC 0.10
  • ADAP -0.00
  • Stochastic Oscillator
  • NTIC 73.03
  • ADAP 47.73

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

Share on Social Networks: